Kofituss Mucolitico (Carbocisteine Lysine)

Carbocisteine reduces mucus viscosity by cleaving disulfide bonds within mucopolysaccharide fibers. This biochemical action thins the secretions, allowing ciliary movement and coughing to clear the mucus more efficiently from the respiratory tract.

The appropriate dose of Kofituss Mucolitico is determined by the prescribing healthcare professional based on the patient’s age, clinical condition, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for carbocisteine during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To request Kofituss Mucolitico, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Carbocisteine (Kofituss Mucolitico) and N‑acetylcysteine are both mucolytics, but they differ in chemical structure and specific mechanisms. Carbocisteine primarily disrupts disulfide bonds in mucus, while N‑acetylcysteine also provides antioxidant effects. Choice of agent depends on clinical judgment, patient tolerance and local guidelines.

Store Kofituss Mucolitico at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity.

Kofituss Mucolitico is taken orally, usually with a glass of water. It may be taken with or without food, according to the prescriber’s guidance. Swallow the tablet or liquid form whole; do not crush or chew unless specifically instructed.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, significant gastrointestinal bleeding, and rare liver injury. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, difficulty breathing, vomiting blood, or jaundice.

Kofituss Mucolitico should be avoided in individuals with known hypersensitivity to carbocisteine or any excipients in the formulation. Caution is also advised for patients with severe hepatic or renal impairment, and it is generally not recommended for use in newborns without specialist advice.